Riitta Sallinen

483 citations
12 papers · 212 indexed · h-index 9
Topics
Pancreatic function and diabetes (3 papers)Diabetes and associated disorders (2 papers)Ion channel regulation and function (2 papers)

In The Last Decade

Riitta Sallinen

12 papers receiving 207 citations

Peers

Riitta Sallinen
Comparison fields: 5 of 56
  • Molecular Biology 97
  • Cellular and Molecular Neuroscience 59
  • Immunology 53
  • Genetics 35
  • Neurology 22
Replace Daniel Feitelberg with:
Daniel Feitelberg United States
David Tran United States
Krzysztof Sadowski Poland
Madeeha H. Sheikh United Kingdom
Andrea Geisz United States
Shu Song China
Debra Mitchell Canada
Sofía Gouveia Spain
Majdi Nagara Tunisia
Riitta Sallinen relative to Daniel Feitelberg United States Daniel Feitelberg's profile →
Citations per field
00.5×3.1×
Daniel Feitelberg · 1×
Citations per year

Countries citing papers authored by Riitta Sallinen

Since Specialization
Citations

This map shows the geographic impact of Riitta Sallinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riitta Sallinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riitta Sallinen more than expected).

Fields of papers citing papers by Riitta Sallinen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Riitta Sallinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riitta Sallinen. The network helps show where Riitta Sallinen may publish in the future.

Co-authorship network of co-authors of Riitta Sallinen

This figure shows the co-authorship network connecting the top 25 collaborators of Riitta Sallinen. A scholar is included among the top collaborators of Riitta Sallinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Riitta Sallinen. Riitta Sallinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 7
2 46
3 10
4 9
5 23
6 29
7 37
8 24
9 2
10 15
11 9
12 1

About Riitta Sallinen

Riitta Sallinen is a scholar working on Pharmacy, Immunology and Allergy and Cellular and Molecular Neuroscience, having authored 12 papers that have together received 212 indexed citations. Recurring topics across this work include Pancreatic function and diabetes (3 papers), Diabetes and associated disorders (2 papers) and Ion channel regulation and function (2 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (59 citations), Immunology (53 citations) and Nephrology (17 citations). Riitta Sallinen has collaborated with scholars based in Finland, United States and Sweden. Frequent co-authors include Maija Wessman, Mari Kaunisto, Kim Pettersson-Fernholm, Carol Forsblom, Per‐Henrik Groop, Johan Fagerudd, Anders Gummesson, Olli Kallioniemi, Göran Bergström and Peter Nilsson. Their work appears in journals such as PLoS ONE, Diabetes and Journal of Nutrition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026